医学
外科肿瘤学
食管胃交界处
腺癌
阶段(地层学)
接收机工作特性
淋巴结
胃切除术
内科学
多元分析
单变量分析
胃肠病学
生存分析
淋巴
放射科
入射(几何)
存活率
风险因素
肿瘤科
淋巴结切除术
切断
胃腺癌
食管切除术
子群分析
淋巴血管侵犯
回顾性队列研究
转移
根治性手术
比例危险模型
淋巴结转移
作者
X. Qin,Zhenguo Gao,Ling Tian,Zhenhong Wang,G. B. Chen,Honghua Song,Yan Xing,Zhenbing Lv,Jiani Hu,Yunhong Tian
标识
DOI:10.1186/s12957-025-04178-2
摘要
The incidence of adenocarcinoma of the esophagogastric junction (AEG) is increasing worldwide. Lymph node metastasis is a crucial prognostic factor in AEG patients. This study investigated the utility of lymph node ratio (LNR, the ratio of metastatic nodes to the total number of examined lymph nodes) in predicting the prognosis of AEG patients. The study conducted a retrospective analysis of 257 patients with AEG who underwent radical gastrectomy with lymphadenectomy. The patients were categorized into low-LNR (L-LNR) and high-LNR (H-LNR) groups, and their corresponding clinicopathological characteristics and survival rates were compared. Receiver Operating Characteristic (ROC) curves were generated to evaluate the sensitivity and specificity of LNR. The cutoff value for dividing the L-LNR group, and the H-LNR group was 0.20. In the L-LNR group, the 1, 3, and 5-year disease-free survival (DFS) rates and overall survival (OS) rates were higher than H-LNR group. Patients in the L-LNR group had better prognoses than those in the H-LNR group (P<0.001). Univariate analysis identified that vascular invasion, lymphatic invasion and LNR were risk factors for DFS and OS. Additionally, multivariate analysis demonstrated that LNR was independent risk factor for DFS and OS. In the subgroup analysis stratified by TNM stage, patients in the L-LNR group demonstrated better DFS and OS compared to those in the H-LNR group. The ROC curve identified that the LNR has good sensitivity and specificity for prognostic prediction in AEG patients, especially in stage III. Patients with LNR greater than 0.2 experienced significantly shorter OS and DFS in patients with AEG, especially in TNM stage III.
科研通智能强力驱动
Strongly Powered by AbleSci AI